UA27738C2 - 2,3,4,5,6,7-hexahydro-1-(4-(1-(4-(2-methoxyphenyl)piperazinyl))-2-phenylbutyryl)-1h-azepine or pharmaceutically acceptable acid addition salt thereof capable of binding to 5-ht receptors, processes for their preparation (variants) and pharmaceutical composition
- Google Patents
2,3,4,5,6,7-hexahydro-1-(4-(1-(4-(2-methoxyphenyl)piperazinyl))-2-phenylbutyryl)-1h-azepine or pharmaceutically acceptable acid addition salt thereof capable of binding to 5-ht receptors, processes for their preparation (variants) and pharmaceutical composition
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джон Вайс Енд Бразер Лімітед, Джон Вайс Енд Бразер ЛимитедfiledCriticalДжон Вайс Енд Бразер Лімітед
Publication of UA27738C2publicationCriticalpatent/UA27738C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
This invention relates to piperazine derivatives, to processes for their preparation, to their use and to pharmaceutical compositions containing them. The novel compounds act on the central nervous system by binding to 5-HT receptors and hence can be used as medicaments for treating humans and other mammals. The novel compounds of the invention are those of the general formula and the pharmaceutically acceptable acid addition salts thereof.
UA93002873A1992-03-161993-06-152,3,4,5,6,7-hexahydro-1-(4-(1-(4-(2-methoxyphenyl)piperazinyl))-2-phenylbutyryl)-1h-azepine or pharmaceutically acceptable acid addition salt thereof capable of binding to 5-ht receptors, processes for their preparation (variants) and pharmaceutical composition
UA27738C2
(en)
2,3,4,5,6,7-hexahydro-1-(4-(1-(4-(2-methoxyphenyl)piperazinyl))-2-phenylbutyryl)-1h-azepine or pharmaceutically acceptable acid addition salt thereof capable of binding to 5-ht receptors, processes for their preparation (variants) and pharmaceutical composition
Derivatives of 1-aryl-2-aminomethyl-cyclopropane-carboxamides (Z), their preparation and their use as medicines in the treatment of disorders of the central nervous system.
Substituted cyclopropylamino-1,3,5-triazines, enantiomers, racemic mixtures or non-toxic, pharmaceutically acceptable acid addition salts thereof possessing pharmacological activity and process for the preparation thereof
(Omega-(diethylamino)-alkoxy)-alpha-(ethyl)-benzhydrol derivatives, their acid addition salts and quaternary salts, process for their preparation and medicines containing these compounds.
Pyridin-2-ylmethyloxy-pyridin-5-ylcarbamoyl-indoline derivatives, a process for the preparation thereof, and a pharmaceutical composition comprising them
2,3,4,5,6,7-hexahydro-1-(4-(1-(4-(2-methoxyphenyl)piperazinyl))-2-phenylbutyryl)-1h-azepine or pharmaceutically acceptable acid addition salt thereof capable of binding to 5-ht receptors, processes for their preparation (variants) and pharmaceutical composition
New 2 - carbonyl substituted n, n'' -di (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them.